|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1935 EUR | +1.84% |
|
+5.16% | +45.49% |
| 06-16 | IntegraGen Enters Receivership Proceedings |  |
| 05-28 | IntegraGen to file for court-ordered receivership | |
Company Valuation: IntegraGen
Data adjusted to current consolidation scope
| Fiscal Period: December | 2019 | 2020 |
|---|---|---|
| Market Cap 1 | 6.536 | 13.61 |
| Change | - | 108.2% |
| Enterprise Value (EV) 1 | 4.017 | 10.5 |
| Change | - | 161.33% |
| P/E | -23x | -36.6x |
| PBR | 2.61x | 6.28x |
| PEG | - | -1.3x |
| Capitalization / Revenue | 0.79x | 1.51x |
| EV / Revenue | 0.49x | 1.17x |
| EV / EBITDA | -37.6x | -375x |
| EV / EBIT | -11.1x | -41.2x |
| EV / FCF | - | - |
| FCF Yield | - | - |
| Dividend per Share 2 | - | - |
| Rate of return | - | - |
| EPS 2 | -0.0439 | -0.0559 |
| Distribution rate | - | - |
| Net sales 1 | 8.28 | 9 |
| EBITDA 1 | -0.107 | -0.028 |
| EBIT 1 | -0.3631 | -0.255 |
| Net income 1 | -0.2848 | -0.375 |
| Net Debt 1 | -2.519 | -3.109 |
| Reference price 2 | 1.0100 | 2.0500 |
| Nbr of stocks (in thousands) | 6,471 | 6,638 |
| Announcement Date | 4/3/20 A | 6/11/21 A |
1EUR in Million2EUR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 1.46M | |
| 49.59x | 6.39x | 23.96x | -.--% | 4.28B | |
| -37.99x | 9.36x | -3775.58x | -.--% | 2.81B | |
| -7.17x | 4.25x | -6.68x | -.--% | 1.75B | |
| 3490.67x | - | - | - | 1.35B | |
| 15.76x | 1.73x | 6.3x | 3.96% | 837M | |
| -16.77x | 3.71x | 25.38x | -.--% | 767M | |
| Average | 582.35x | 5.09x | -745.32x | 0.79% | 1.68B | |
| Weighted average by Cap. | 408.43x | 6.26x | -1,004.02x | 0.32% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALINT Stock
- Valuation IntegraGen
Select your edition
All financial news and data tailored to specific country editions
